4/6/2020  9:59:54 PM Chg. +1.72 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
32.89USD +5.52% 475,571
Turnover: 15.6 mill.
-Bid Size: - -Ask Size: - 45.91 bill.USD 0.00% 9.73

Business description

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
 

Management board & Supervisory board

CEO
Michael F. Mahoney
Management board
Daniel J. Brennan, Art Butcher, Brad Sorenson, David A. Pierce, Desiree Ralls-Morrison, Edward Mackey, Eric Thépaut, Ian Meredith, Jeff Mirviss, Jodi Eddy, Joseph M. Fitzgerald, Kevin Ballinger, Maulik Nanavaty, Warren Wang, Wendy Carruthers
Supervisory board
Michael F. Mahoney, Charles J. Dockendorff, David J. Roux, Donna A. James, Edward J. Ludwig, Ellen Zane, John E. Sununu, Nelda J. Connors, Stephen P. MacMillan, Yoshiaki Fujimori
 

Company data

Name: Boston Scientific Corp.
Address: 300 Boston Scientific Way,Marlborough, Massachusetts 01752-1234, USA
Phone: +1-508-683-4000
Fax: -
E-mail: -
Internet: www.bsci.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 68.12%
IPO date: -

Investor relations

Name: Susan Lisa
IR phone: +1-508-683-5670
IR Fax: +1-508-683-5675
IR e-mail: BSXInvestorRelations@bsci.com

Company calendar

CW 19 | 5/7/2020 General Shareholder Meeting
 

Main Shareholders

Freefloat
 
68.12%
FMR LLC/ Abigail P. Johnson
 
9.11%
The Vanguard Group, Inc.
 
7.79%
Capital World Investors
 
7.72%
BlackRock, Inc.
 
7.26%